With a need to boost its public profile and the excellent work it was doing developing neurotherapeutics to reduce brain damage after stroke, Argenica began a PR program with Profile Media to raise awareness and influence amongst stakeholders and the broader community.

The program was an instant success. Argenica has been a regular monthly staple in the media, with appearances in outlets such as Channel 9 News (nationally), ABC Radio, The West Australian, Medical Forum, Canberra Times, 2GB Healthy Living, and many more.

CEO Liz Dallimore is now a recognised and experienced commentator not only in the health space in which Argenica operates, but also on topics such as leadership, medical investment and the biotech industry more generally.